Cancer patients from migrant backgrounds have a 1 in 3 chance of something going wrong in their care
In countries around the world, evidence suggests people from CALD backgrounds are at increased risk of harm as a result of ...
The American Journal of Managed Care1d
Long-Term Effects of COVID-19 Disruptions on Cancer Care Still Unfolding: Dan Nardi, MS
The long-term impact of disruptions in oncology care during the COVID-19 pandemic will become more apparent in the coming years, according to Dan Nardi, MS, of Reimagine Care.
Low-dose apixaban comparable to full dose for preventing venous thromboembolism recurrence in patients with cancer
Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning ...
News-Medical.Net3d
Reduced-dose apixaban proves effective in preventing blood clot recurrence in cancer patients
Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning medication for at least six months, followed by an additional 12 months of ...
MedPage Today on MSN4d
Lower-Dose Extended Anticoagulation Just as Effective for VTE With Active Cancer
For extended anticoagulation after venous thromboembolism (VTE) in patients with active cancer, a lower dose of apixaban ...
CURE5d
Why Physical Therapy Should Begin at the Time of a Cancer Diagnosis
Early physical therapy initiation at cancer diagnosis can prevent or minimize treatment-related side effects, enhancing ...